NR-52161鲍曼不动杆菌,MRSN3360(细菌）
产品图片
货号/SKU
NR-52161
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52161??Acinetobacter baumannii, MRSN 3360(Bacteria)|Acinetobacter baumannii|MRSN 3360|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 3360, NR-52161. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 3360 was isolated in 2011 from a human blood sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 3360 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52161 was deposited as multi-locus sequence type (MLST) ST 499, sensitive to amikacin, ceftazidime, colistin and ceftriaxone, intermediately resistant to tobramycin and tetracycline and resistant to ciprofloxacin, cefepime, gentamicin, imipenem, levofloxacin, meropenem, ampicillin/sulbactam and trimethoprim/sulfamethoxazole. Strain MRSN 3360 is reported to have one aminoglycoside transferase gene [ant(2”)-Ia; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-95 and blaOXA-23; conferring resistance to beta-lactams), one sulfonamide resistance gene (sul1; conferring resistance to sulfonamides), one chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), one dihydrofolate reductase gene (dfrA19; conferring resistance to trimethoprim), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides] and one ABC-F type ribosomal protection protein/ABC-F subfamily protein [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics]. The complete genome of A. baumannii, strain MRSN 3360 is available (GenBank: VHEZ00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 3360 was isolated in 2011 from a human blood sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 3360 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52161 was deposited as multi-locus sequence type (MLST) ST 499, sensitive to amikacin, ceftazidime, colistin and ceftriaxone, intermediately resistant to tobramycin and tetracycline and resistant to ciprofloxacin, cefepime, gentamicin, imipenem, levofloxacin, meropenem, ampicillin/sulbactam and trimethoprim/sulfamethoxazole. Strain MRSN 3360 is reported to have one aminoglycoside transferase gene [ant(2”)-Ia; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-95 and blaOXA-23; conferring resistance to beta-lactams), one sulfonamide resistance gene (sul1; conferring resistance to sulfonamides), one chloramphenicol acetyltransferase gene (catB3; conferring resistance to chloramphenicol), one dihydrofolate reductase gene (dfrA19; conferring resistance to trimethoprim), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolides] and one ABC-F type ribosomal protection protein/ABC-F subfamily protein [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics]. The complete genome of A. baumannii, strain MRSN 3360 is available (GenBank: VHEZ00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
AcineTobacter Baumannii（A.Baumannii），菌株MRSN 3360在2011年从美国的人血样品中分离，作为全球监测计划的一部分.
a. Baumannii ，将菌株MRSN 3360作为MRSN Baumannii 的一部分沉积，从BEI资源作为NR-52248获得的多样性面板. NR-52161沉积为多基因座序列类型（MLST）ST 499，对Amikacin，Ceftazidime，Colistin和头孢霉素和头孢霉素和四环素中的中间霉素和四环素，对环氟氯嘧汀，头孢酮，庆大霉素，伊皮脂，左氧氟普林，梅洛宾，氨苄青霉素/舒巴坦和甲磺基甲恶唑.据报道，菌株MRSN 3360具有一个氨基糖苷类转移酶基因[蚂蚁 - IA） - IA;赋予各种氨基糖苷的耐药性，三种β-内酰胺酶基因（ BLA ADC-25 ， BLA Oxa-95 和 bla oxa-23 ;赋予β-内酰胺酸酯），一种磺酰胺抗性基因（ sul 1;赋予硫磺酰胺），一个氯霉素乙酰转移酶基因（猫 B3;赋予氯霉素抗性），一种二氢酚酸盐还原酶基因（ DFR-i> A19;赋予Trimethokim的抵抗力），一种大环内酯磷酸转移酶基因[ MPH （e）;赋予大溴化胶质的抗性]和一个ABC-F型核糖体保护蛋白/ ABC-F亚家族蛋白[ MSR （E）;赋予红霉素和链图B抗生素的抗性. a的完整基因组. Baumannii ，菌株MRSN 3360可用（Genbank：）. >
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2024-01-21
2021-10-31
2019-05-08
2022-04-01
2021-12-21
2022-04-01
2022-04-01
2021-12-21
2022-06-17
2021-12-21
2024-01-21
2024-01-21
2023-11-12
2024-05-19